Total Credits: 1 including 1 AOA Category 1-A Credit(s)
*** Please note this program was a part of the MOA ‘s 114th Annual Convention. You will not want to choose this program if you completed this individual program as part of the MOA’s 114th Annual Convention.***
Learning Objectives:
- Recall buprenorphine pharmacologic properties and indications for pain and OUD.
- Discuss the evidence for treatment of chronic pain with buprenorphine.
- Identify patients eligible for opioid rotation to buprenorphine, including those with Complex Persistent Opioid Dependence.
- Describe the process of initiating buprenorphine in various chronic pain scenarios.
This session is accredited for a maximum of 1.0 AOA Category 1-A credits. Credits commensurate with participation in the session will be awarded.
MOA Grievance Policy: All grievances should be initially directed in writing to the MOA Executive Director by email to info@mainedo.org who will share them with the MOA's Program Committee. Grievances will receive a response within 30 days of receipt. If you do not receive a satisfactory response, you may notify the Council on Continuing Medical Education, AOA, 142 East Ontario St., Chicago, IL 60611.
| Initiation of Buprenorphine for the Treatment of Pain (1.2 MB) | Available after Purchase | ||
Dr. Sara Happel is a former ER and home health nurse turned Palliative Care Physician. She works at Eastern Maine Medical Center providing symptom management and general guidance to folks living with cancer and other complex progressive medical diseases and has a particular interest in the intersection of substance use disorder, mental health, and chronic pain, as well as expending access to underserved communities.
Dr. Happel has not financial disclosures pertaining to this lecture.
Whitney Jandreau is a Controlled Substances Stewardship Clinical Pharmacist Specialist at Northern Light Sebasticook Valley Hopsital & Primary Care. Her practice experience includes a PGY1 Pharmacy Practice Residency at VA Maine Healthcare System followed by 8 years of inpatient practice before transitioning to her inpatient/outpatient position a year ago. Whitney has a clinical passion for substance use disorder and pain management.
Whitney has no financial disclosures toward this lecture.
| 5 |
|
| 4 |
|
| 3 |
|
| 2 |
|
| 1 |
|
